IIM
COGT icon

INTECH Investment Management’s Cogent Biosciences COGT Stock Holding History

INTECH Investment Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.63M Sell
42,330
-19,260
-31% -$711K 0.02% 786
2025
Q4 		$2.19M Buy
61,590
+23,311
+61% +$655K 0.02% 698
2025
Q3 		$550K Sell
38,279
-17,138
-31% -$203K ﹤0.01% 1527
2025
Q2 		$398K Sell
55,417
-1,788
-3% -$9.91K ﹤0.01% 1734
2025
Q1 		$343K Buy
57,205
+548
+1% +$4.3K ﹤0.01% 1811
2024
Q4 		$442K Buy
56,657
+28,233
+99% +$281K ﹤0.01% 1632
2024
Q3 		$307K Buy
+28,424
New +$277K ﹤0.01% 1508

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

INTECH Investment Management's COGT Position: Q1 2026 in Review

INTECH Investment Management reduced its Cogent Biosciences (COGT) stake by 31% in Q1 2026, selling an estimated $711K and leaving 42,330 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #786.

INTECH Investment Management first reported a position in COGT in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.19M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • INTECH Investment Management held 42,330 shares of Cogent Biosciences worth $1.63M as of Q1 2026.
  • INTECH Investment Management sold 19,260 Cogent Biosciences shares in Q1 2026, an estimated $711K.
  • Cogent Biosciences made up 0.02% of INTECH Investment Management's portfolio in Q1 2026, its #786 holding.
  • INTECH Investment Management first reported a position in Cogent Biosciences in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Cogent Biosciences position peaked at $2.19M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.